Ian Croy
Edinburgh, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Evaluation of quantitative polymerase chain reaction for detecting BRCA1 or BRCA2 copy number loss in high-grade serous ovarian cancer.
Journal: Scientific reports
Published: November 12, 2025
Combined genomic and molecular analysis defines prognostic markers of relapse in stage IA-IC1 clear cell ovarian carcinoma.
Journal: Gynecologic oncology
Published: April 01, 2025
Antibody drug conjugate targets are highly differentially expressed across the major types of ovarian cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 24, 2025
Somatic BRCA1/2 mutations are associated with a similar survival advantage to their germline counterparts in tubo-ovarian high grade serous carcinoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 10, 2024
Divergent trajectories to structural diversity impact patient survival in high grade serous ovarian cancer.
Journal: Nature communications
Published: October 03, 2024
Whole exome sequencing reveals diverse genomic relatedness between paired concurrent endometrial and ovarian carcinomas.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 13, 2024
Compartment-specific multiomic profiling identifies SRC and GNAS as candidate drivers of epithelial-to-mesenchymal transition in ovarian carcinosarcoma.
Journal: British journal of cancer
Published: May 11, 2023
Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinoma.
Journal: Scientific reports
Published: November 30, 2022
Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 02, 2022
Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high-grade serous carcinoma.
Journal: British journal of cancer
Published: February 01, 2022
Integrated molecular characterisation of endometrioid ovarian carcinoma identifies opportunities for stratification.
Journal: NPJ precision oncology
Published: November 23, 2020
Last Updated: 09/26/2026